This information was published on 2026-07-27T00:12:11 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2661526 (IR 1922072) |
| (220) |
17 Apr 2026
|
| (300) |
TO, 26 Feb 2026, TO/M/2026/05032
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, generalized anxiety disorder (gad) and major depressive disorder (mdd). |
| (540) | NEUPLIXO |
| (550) | Word |
| (730) |
Definium Therapeutics US, Inc.
|
Find out more about publications on the About page.